Document is current
Any future updates will be listed below
-
Authors
Baylous, Kyle
Helbock, Ryan
Kovarovic, Brandon
Slepian, Marvin J.
Bluestein, Danny https://orcid.org/0000-0002-4014-2308
-
Funding
Funding for this research was provided by:
National Institute of Biomedical Imaging and Bioengineering (BRP U01 EB026414)
National Heart, Lung, and Blood Institute (R41 HL134418)
National Heart, Lung, and Blood Institute (R42 HL134418)
- License Information
-
More Information
Article History
Received: 19 July 2025
Accepted: 13 October 2025
First Online: 20 November 2025
Declarations
:
: The authors DB and MS have an equity interest in PolyNova Cardiovascular Inc.
: The current research was approved by the Office of Research Compliance and Internal Review Board (IRB) of Stony Brook University. All procedures involving human participants were in accordance with the Helsinki Declaration of 1964, as revised in 2000 and 2008. No animal testing was conducted in this study.
: Not applicable.
: All authors have reviewed and approved the final manuscript and fully consent to its submission for publication.
